Search

Author/Creator Iwata, Hiroji

2. A phase I/II pharmacokinetics/pharmacodynamics study of irinotecan combined with S−1 for recurrent/metastatic breast cancer in patients with selected UGT1A1 genotypes (the JBCRG‐M01 study). (13th November 2017)

Authors:
Ishiguro, Hiroshi; Saji, Shigehira; Nomura, Shogo; Tanaka, Sunao; Ueno, Takayuki; Onoue, Masahide; Iwata, Hiroji; Yamanaka, Takeharu; Sasaki, Yasutsuna; Toi, Masakazu
Journal:
Cancer medicine
Issue:
Volume 6:Number 12(2018:Dec.)
Page Start:
2909
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

3. A randomized phase III study comparing trastuzumab emtansine with trastuzumab, pertuzumab and docetaxel in elderly patients with advanced stage HER2-positive breast cancer: Japan Clinical Oncology Group Study (JCOG1607, HERB TEA study). (2nd July 2021)

Authors:
Shimomura, Akihiko; Tamura, Kenji; Tanaka, Kiyo; Mizutani, Tomonori; Sasaki, Keita; Sekino, Yuta; Sawaki, Masataka; Shien, Tadahiko; Shibata, Taro; Iwata, Hiroji
Journal:
Japanese journal of clinical oncology
Issue:
Volume 51:Number 9(2021)
Page Start:
1471
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

4. A randomized, open-label, Phase III trial of pertuzumab retreatment in HER2-positive locally advanced/metastatic breast cancer patients previously treated with pertuzumab, trastuzumab and chemotherapy: the Japan Breast Cancer Research Group-M05 PRECIOUS study. (18th July 2018)

Authors:
Yamamoto, Yutaka; Iwata, Hiroji; Ueno, Takayuki; Taira, Naruto; Kashiwaba, Masahiro; Takahashi, Masato; Tada, Hiroshi; Tsugawa, Koichiro; Toyama, Tatsuya; Niikura, Naoki; Hara, Fumikata; Fujisawa, Tomomi; Yoshinami, Tetsuhiro; Saji, Shigehira; Takano, Toshimi; Masuda, Norikazu; Morita, Satoshi; T...
Journal:
Japanese journal of clinical oncology
Issue:
Volume 48:Number 9(2018)
Page Start:
855
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

5. A systematic literature review of prognostic factors in patients with HR+/HER2− advanced breast cancer in Japan. (21st August 2021)

Authors:
Hattori, Masaya; Novick, Diego; Takaura, Kana; Tanizawa, Yoshinori; Kawaguchi, Tsutomu; Haro, Josep Maria; Monistrol-Mula, Anna; Onishi, Akira; Iwata, Hiroji
Journal:
Japanese journal of clinical oncology
Issue:
Volume 51:Number 10(2021)
Page Start:
1498
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

6. Abemaciclib in combination with endocrine therapy for East Asian patients with HR+, HER2− advanced breast cancer: MONARCH 2 & 3 trials. Issue 6 (1st May 2021)

Authors:
Toi, Masakazu; Inoue, Kenichi; Masuda, Norikazu; Iwata, Hiroji; Sohn, Joohyuk; Hae Park, In; Im, Seock‐Ah; Chen, Shin‐Cheh; Enatsu, Sotaro; Turner, P. Kellie; André, Valérie A. M.; Hardebeck, Molly C.; Sakaguchi, Sachi; Goetz, Matthew P.; Sledge, George W.
Journal:
Cancer science
Issue:
Volume 112:Issue 6(2021)
Page Start:
2381
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

9. Adjuvant denosumab in early breast cancer (D-CARE): an international, multicentre, randomised, controlled, phase 3 trial. Issue 1 (January 2020)

Authors:
Coleman, Robert; Finkelstein, Dianne M; Barrios, Carlos; Martin, Miguel; Iwata, Hiroji; Hegg, Roberto; Glaspy, John; Periañez, Alvaro Montaño; Tonkin, Katia; Deleu, Ines; Sohn, Joohyuk; Crown, John; Delaloge, Suzette; Dai, Tian; Zhou, Ying; Jandial, Danielle; Chan, Arlene
Journal:
Lancet oncology
Issue:
Volume 21:Issue 1(2020)
Page Start:
60
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

10. Adjuvant S-1 plus endocrine therapy for oestrogen receptor-positive, HER2-negative, primary breast cancer: a multicentre, open-label, randomised, controlled, phase 3 trial. Issue 1 (January 2021)

Authors:
Toi, Masakazu; Imoto, Shigeru; Ishida, Takanori; Ito, Yoshinori; Iwata, Hiroji; Masuda, Norikazu; Mukai, Hirofumi; Saji, Shigehira; Shimizu, Akira; Ikeda, Takafumi; Haga, Hironori; Saeki, Toshiaki; Aogi, Kenjiro; Sugie, Tomoharu; Ueno, Takayuki; Kinoshita, Takayuki; Kai, Yuichiro; Kitada, Masahir...
Journal:
Lancet oncology
Issue:
Volume 22:Issue 1(2021)
Page Start:
74
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗